tadalafil has been researched along with Nervous System Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brandetti, F; Carosa, E; Jannini, EA; Lombardo, F; Martini, P | 1 |
| Ballanger, P; Calvet, C; Eftekhari, P; Farghal, H; Martin, K; Molimard, M; Moore, N; Robert, G | 1 |
1 review(s) available for tadalafil and Nervous System Diseases
| Article | Year |
|---|---|
The therapeutic dilemma: how to use tadalafil.
Topics: Carbolines; Diabetes Complications; Endothelium, Vascular; Erectile Dysfunction; Half-Life; Humans; Male; Nervous System Diseases; Penile Erection; Phosphodiesterase Inhibitors; Tadalafil; Vasodilator Agents | 2005 |
1 other study(ies) available for tadalafil and Nervous System Diseases
| Article | Year |
|---|---|
[Treatment of erectile dysfunction by phosphodiesterase-5 inhibitors and nonarteritic anterior ischemic optic neuropathy (NOIAN)].
Topics: Biopsy; Carbolines; Erectile Dysfunction; Humans; Male; Nervous System Diseases; Phosphodiesterase 5 Inhibitors; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones; Tadalafil; United States; United States Food and Drug Administration | 2007 |